May 14 | In-Person & Digital (New York)

US PHARMA AND BIOTECH SUMMIT

How will the FDA adapt to the rise of China?

For the first time in its 50-year history, US biotech faces a genuine global challenger. China's life sciences sector has exploded, and it's redrawing the competitive map in real time.

At the US Pharma and Biotech Summit 2026, industry leaders will tackle the hard questions head-on. Can US regulators keep up with China's biopharma surge? And if they overcorrect, who pays the price? 

Join 300+ senior executives, investors, and policymakers for a day of candid, high-level conversation in New York. If you want to know where US biopharma is headed — and who's steering — register now to secure your place.